157 related articles for article (PubMed ID: 19756959)
1. Increased liver oxidative stress and altered PUFA metabolism precede development of non-alcoholic steatohepatitis in SREBP-1a transgenic spontaneously hypertensive rats with genetic predisposition to hepatic steatosis.
Malínská H; Oliyarnyk O; Hubová M; Zídek V; Landa V; Simáková M; Mlejnek P; Kazdová L; Kurtz TW; Pravenec M
Mol Cell Biochem; 2010 Feb; 335(1-2):119-25. PubMed ID: 19756959
[TBL] [Abstract][Full Text] [Related]
2. A new transgenic rat model of hepatic steatosis and the metabolic syndrome.
Qi NR; Wang J; Zidek V; Landa V; Mlejnek P; Kazdová L; Pravenec M; Kurtz TW
Hypertension; 2005 May; 45(5):1004-11. PubMed ID: 15809359
[TBL] [Abstract][Full Text] [Related]
3. Identification of mutated Srebf1 as a QTL influencing risk for hepatic steatosis in the spontaneously hypertensive rat.
Pravenec M; Kazdova L; Landa V; Zidek V; Mlejnek P; Simakova M; Jansa P; Forejt J; Kren V; Krenova D; Qi N; Wang JM; Chan D; Aitman TJ; Kurtz TW
Hypertension; 2008 Jan; 51(1):148-53. PubMed ID: 18071061
[TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic fatty liver disease in HIV infection associated with altered hepatic fatty acid composition.
Arendt BM; Mohammed SS; Ma DW; Aghdassi E; Salit IE; Wong DK; Guindi M; Sherman M; Heathcote EJ; Allard JP
Curr HIV Res; 2011 Mar; 9(2):128-35. PubMed ID: 21434863
[TBL] [Abstract][Full Text] [Related]
5. Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion.
Pettinelli P; Del Pozo T; Araya J; Rodrigo R; Araya AV; Smok G; Csendes A; Gutierrez L; Rojas J; Korn O; Maluenda F; Diaz JC; Rencoret G; Braghetto I; Castillo J; Poniachik J; Videla LA
Biochim Biophys Acta; 2009 Nov; 1792(11):1080-6. PubMed ID: 19733654
[TBL] [Abstract][Full Text] [Related]
6. The role of hepatic liver X receptor α- and sterol regulatory element binding protein-1c-mediated lipid disorder in the pathogenesis of non-alcoholic steatohepatitis in rats.
Ai ZL; Zhu CH; Min M; Wang J; Lan CH; Fan LL; Sun WJ; Chen DF
J Int Med Res; 2011; 39(4):1219-29. PubMed ID: 21986124
[TBL] [Abstract][Full Text] [Related]
7. Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice.
López-Oliva ME; Garcimartin A; Muñoz-Martínez E
Br J Nutr; 2017 Dec; 118(11):914-929. PubMed ID: 29173234
[TBL] [Abstract][Full Text] [Related]
8. Prebiotic approach alleviates hepatic steatosis: implication of fatty acid oxidative and cholesterol synthesis pathways.
Pachikian BD; Essaghir A; Demoulin JB; Catry E; Neyrinck AM; Dewulf EM; Sohet FM; Portois L; Clerbaux LA; Carpentier YA; Possemiers S; Bommer GT; Cani PD; Delzenne NM
Mol Nutr Food Res; 2013 Feb; 57(2):347-59. PubMed ID: 23203768
[TBL] [Abstract][Full Text] [Related]
9. Role of endoplasmic reticulum stress and oxidative stress in vinyl chloride-induced hepatic steatosis in mice.
Wang Q; Zhang L; Chen SQ; Ma WY; Guo YL; Gao Y; Tian FJ; Qiu YL
Toxicol Appl Pharmacol; 2019 Oct; 381():114730. PubMed ID: 31445928
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of angiotensin II type 1 receptor blocker, irbesartan, on non-alcoholic steatohepatitis using FLS-ob/ob male mice.
Kato J; Koda M; Kishina M; Tokunaga S; Matono T; Sugihara T; Ueki M; Murawaki Y
Int J Mol Med; 2012 Jul; 30(1):107-13. PubMed ID: 22469867
[TBL] [Abstract][Full Text] [Related]
11. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice.
Yamamoto T; Nakade Y; Yamauchi T; Kobayashi Y; Ishii N; Ohashi T; Ito K; Sato K; Fukuzawa Y; Yoneda M
World J Gastroenterol; 2016 Feb; 22(8):2512-23. PubMed ID: 26937139
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of granulocyte-colony stimulating factor on non-alcoholic hepatic steatosis in the rat.
Song YS; Fang CH; So BI; Park JY; Jun DW; Kim KS
Ann Hepatol; 2013; 12(1):115-22. PubMed ID: 23293202
[TBL] [Abstract][Full Text] [Related]
14. Iron-induced pro-oxidant and pro-lipogenic responses in relation to impaired synthesis and accretion of long-chain polyunsaturated fatty acids in rat hepatic and extrahepatic tissues.
Valenzuela R; Rincón-Cervera MÁ; Echeverría F; Barrera C; Espinosa A; Hernández-Rodas MC; Ortiz M; Valenzuela A; Videla LA
Nutrition; 2018 Jan; 45():49-58. PubMed ID: 29129237
[TBL] [Abstract][Full Text] [Related]
15. Polydatin alleviates non-alcoholic fatty liver disease in rats by inhibiting the expression of TNF-α and SREBP-1c.
Zhang J; Tan Y; Yao F; Zhang Q
Mol Med Rep; 2012 Oct; 6(4):815-20. PubMed ID: 22858825
[TBL] [Abstract][Full Text] [Related]
16. Enhancing hepatic fibrosis in spontaneously hypertensive rats fed a choline-deficient diet: a follow-up report on long-term effects of oxidative stress in non-alcoholic fatty liver disease.
Yamamoto H; Kanno K; Ikuta T; Arihiro K; Sugiyama A; Kishikawa N; Tazuma S
J Hepatobiliary Pancreat Sci; 2016 May; 23(5):260-9. PubMed ID: 26880573
[TBL] [Abstract][Full Text] [Related]
17. Endogenously elevated n-3 polyunsaturated fatty acids alleviate acute ethanol-induced liver steatosis.
Huang W; Wang B; Li X; Kang JX
Biofactors; 2015; 41(6):453-62. PubMed ID: 26637972
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of SREBP-1c is associated with the development of burned-out NASH.
Nagaya T; Tanaka N; Suzuki T; Sano K; Horiuchi A; Komatsu M; Nakajima T; Nishizawa T; Joshita S; Umemura T; Ichijo T; Matsumoto A; Yoshizawa K; Nakayama J; Tanaka E; Aoyama T
J Hepatol; 2010 Oct; 53(4):724-31. PubMed ID: 20655124
[TBL] [Abstract][Full Text] [Related]
19. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
20. Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity.
Walle P; Takkunen M; Männistö V; Vaittinen M; Lankinen M; Kärjä V; Käkelä P; Ågren J; Tiainen M; Schwab U; Kuusisto J; Laakso M; Pihlajamäki J
Metabolism; 2016 May; 65(5):655-666. PubMed ID: 27085774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
